Skroot — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Skroot Laboratory has developed an innovative sensor-based platform for remote, real-time monitoring of cell cultures, addressing a critical bottleneck in biomanufacturing and cell therapy production. Its core SMART technology uses passive, single-use sensors that absorb metabolites and are read by an external device, enabling continuous data collection without sampling. The company is positioned as a tools and diagnostics provider, offering a modular and cost-effective solution compatible with various culture vessels and cell types. Skroot appears to be a private, early-stage company leveraging its patented platform to penetrate the growing advanced therapy and bioproduction markets.

DiagnosticsAI / Machine Learning

Technology Platform

SMART Platform: Single-use, Metabolite Absorbing, Resonant Transducer sensors for contact-free, real-time monitoring of cell growth in culture vessels. Includes passive sensor stickers, an external RF reader, and cloud-based data analytics software.

Opportunities

The rapid growth of cell and gene therapy manufacturing, which is heavily constrained by a lack of robust, non-invasive process monitoring tools, presents a primary opportunity.

The industry-wide shift towards single-use technologies and demand for continuous data for process control and optimization further drives adoption potential for Skroot's low-cost, disposable sensor platform.

Risk Factors

Key risks include technological validation across diverse cell types and complex media, competition from established alternative monitoring methods, and the commercial challenge of integrating into existing bioreactor ecosystems as a small company.

Financial risk associated with being a pre-revenue, private entity needing to raise capital to scale is also significant.

Competitive Landscape

Skroot competes with other bioprocess monitoring technologies, including optical methods (e.g., Raman spectroscopy, near-infrared), dielectric spectroscopy (for biomass), and traditional offline analytics. Its key differentiators are its non-optical design (works with opaque vessels), passive single-use sensor format, and very low cost per data point, positioning it for high-throughput and single-use applications where other technologies may be too expensive or complex.

More companies in Digital Health & Biotech SaaS →More companies in United States →